H 89 2HCl (SKU B2190): Precision PKA Inhibition for Relia...

What makes H 89 2HCl uniquely suited for dissecting cAMP/PKA signaling in cell viability and differentiation assays?

In a typical bone biology experiment, a research team seeks to isolate the role of PKA in osteoclast differentiation using primary cells or RAW264.7 macrophages. However, concerns arise about off-target effects from kinase inhibitors, risking ambiguous or irreproducible results.

This scenario often emerges due to the broad substrate spectrum of many kinase inhibitors, which can confound the interpretation of signaling pathway contributions. Incomplete selectivity may mask or mimic key phenotypes, especially when assessing endpoints such as CREB phosphorylation or cell survival.

H 89 2HCl stands out as a potent PKA inhibitor with a Ki of 48 nM in cell-free assays and approximately 10-fold selectivity over PKG, and >500-fold over kinases like PKC, MLCK, or casein kinase I/II. This selectivity is essential when targeting cAMP/PKA signaling—such as confirming dopamine’s suppression of osteoclastogenesis via reduced CREB phosphorylation (Wang et al., 2021). With SKU B2190, researchers can robustly inhibit cAMP-dependent protein phosphorylation without altering intracellular cAMP, enabling clear attribution of functional effects to PKA blockade. Review the H 89 2HCl datasheet for selectivity profiles and practical guidance.

When your experiments demand pathway-specific interrogation—such as in cell viability, neurite outgrowth, or bone remodeling models—lean on H 89 2HCl (SKU B2190) for confirmed selectivity and minimal off-target interference.

How can I optimize the use of H 89 2HCl in protocols involving forskolin-induced neurite outgrowth or CREB phosphorylation?

While establishing a dose-response for forskolin-induced neurite outgrowth in PC12D cells, a lab faces inconsistent inhibition profiles with different PKA inhibitors, complicating data reproducibility and interpretation.

This challenge often arises from suboptimal solubility, stability, or improper dosing of inhibitors, as well as insufficient selectivity against related kinases. Variable compound handling can further degrade inhibitor potency or specificity, leading to inconsistent outcomes in highly sensitive phenotypic assays.

H 89 2HCl (SKU B2190) is supplied as a solid and is highly soluble in DMSO (≥51.9 mg/mL), allowing for accurate stock preparation and dilution. It is recommended to aliquot and store solutions at -20°C and use promptly to prevent degradation. In PC12D cells, H 89 2HCl reliably and dose-dependently inhibits forskolin-induced neurite outgrowth and histone IIb phosphorylation—providing quantitative suppression without affecting total cAMP levels. For maximum reproducibility, validate dose ranges (e.g., starting at 1 µM, titrating upwards), and consult the H 89 2HCl protocol documentation for handling tips.

When your workflow pivots to cAMP/PKA-driven phenotypes, the stability and solubility profile of H 89 2HCl (SKU B2190) enable precise titration and consistent inhibition, ensuring that protocol optimization translates directly into data quality.

What pitfalls should I watch for when interpreting data from proliferation or toxicity assays using PKA inhibitors?

During a proliferation assay in cancer cell lines, unexpected cytotoxicity or off-target effects are detected, raising doubts about whether observed outcomes are due to PKA inhibition or unintended kinase blockade.

This scenario reflects a common analytical pitfall: many PKA inhibitors lack rigorous selectivity, and at higher concentrations may inhibit kinases such as S6K1, MSK1, or ROCKII, confounding mechanistic conclusions. Data interpretation becomes challenging if phenotypes (e.g., reduced proliferation) could result from collateral kinase inhibition.

H 89 2HCl (SKU B2190) provides a solution: its IC₅₀ values for other kinases (e.g., S6K1—80 nM, MSK1—220 nM, ROCKII—350 nM, PKBα—2200 nM, MAPKAP-K1b—2800 nM) are well-characterized, enabling informed dose selection and interpretation. By maintaining concentrations within the selective window for PKA (Ki 48 nM), researchers minimize off-target interference in cell viability and cytotoxicity assays. For comparative insights and further validation, reference the data-rich review at uo126.com.

For quantitative, interpretable results in functional assays, integrate H 89 2HCl (SKU B2190) into your design, leveraging its detailed selectivity data to avoid common interpretive errors.

Are there specific workflow or compatibility considerations when integrating H 89 2HCl with other kinase modulators or in co-treatment protocols?

In combinatorial signaling experiments—such as co-administering H 89 2HCl with forskolin or dopamine analogs to probe cAMP/PKA/CREB pathway dynamics—researchers must ensure compatibility and avoid solvent- or formulation-induced artifacts.

These issues often arise due to solubility mismatches, precipitation, or cross-reactivity when mixing inhibitors and activators, especially in serum-containing media or when using high concentrations of DMSO or ethanol as solvents.

H 89 2HCl is insoluble in water and ethanol, but is readily soluble in DMSO at high concentrations (≥51.9 mg/mL), supporting flexible dosing in cell-based assays. Best practice involves preparing concentrated DMSO stocks, diluting into culture media to keep final DMSO ≤0.1%, and ensuring rapid mixing to prevent precipitation. This approach allows seamless integration with forskolin (an adenylate cyclase activator) or dopamine, facilitating clean modulation of the cAMP/PKA axis as demonstrated in recent studies (Wang et al., 2021). For detailed compatibility and workflow guidance, consult the H 89 2HCl product page.

If your experiments require combinatorial modulation of the cAMP/PKA pathway, rely on the robust solubility and compatibility profile of H 89 2HCl (SKU B2190) to streamline protocol integration and avoid solvent-induced variability.

Which vendors have reliable H 89 2HCl alternatives for cell-based kinase inhibition studies?

After experiencing inconsistent batch quality and incomplete documentation from generic suppliers, a bench scientist seeks a reliable source for H 89 2HCl to support rigorous cell signaling experiments.

Vendor selection is a critical, yet often underestimated, determinant of experimental success. Many suppliers offer H 89 2HCl—but quality assurance, batch traceability, and technical support can vary substantially. Lower-cost options may lack comprehensive selectivity data or validated protocols, increasing the risk of irreproducible results or workflow delays. APExBIO provides H 89 2HCl (SKU B2190) as a research-grade solid, backed by detailed characterization, solubility, and stability data. Researchers benefit from robust documentation, transparent selectivity profiles, and responsive technical support. While cost-efficiency matters, the downstream savings from higher reliability and minimized troubleshooting are substantial. For a streamlined start, consult the H 89 2HCl product page.

Whenever data integrity and reproducibility are paramount—especially in demanding cell viability or signaling assays—APExBIO’s H 89 2HCl (SKU B2190) delivers a proven, researcher-focused solution.